| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 10820414
[patent_doc_number] => 20160166578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'METHOD FOR TREATING TYPE I AND TYPE II DIABETES'
[patent_app_type] => utility
[patent_app_number] => 14/436674
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7999
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436674 | METHOD FOR TREATING TYPE I AND TYPE II DIABETES | Oct 20, 2013 | Abandoned |
Array
(
[id] => 9422442
[patent_doc_number] => 20140107093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE'
[patent_app_type] => utility
[patent_app_number] => 14/053737
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18193
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053737
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053737 | Compounds useful as inhibitors of ATR kinase | Oct 14, 2013 | Issued |
Array
(
[id] => 9409040
[patent_doc_number] => 20140100292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets'
[patent_app_type] => utility
[patent_app_number] => 14/048439
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5015
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048439
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048439 | Use of moisture-conditioned disintegrants or expanding agents in tablet manufacture for the selective adjustment of the mechanical properties, the dissolving kinetics and/or the water loading of the tablets | Oct 7, 2013 | Abandoned |
Array
(
[id] => 9408984
[patent_doc_number] => 20140100236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets'
[patent_app_type] => utility
[patent_app_number] => 14/048445
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14285
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048445
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048445 | Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets | Oct 7, 2013 | Abandoned |
| 14/040266 | COMPOSITION AND METHOD OF TREATING SKIN CONDITIONS | Sep 26, 2013 | Abandoned |
Array
(
[id] => 9319364
[patent_doc_number] => 20140051702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis'
[patent_app_type] => utility
[patent_app_number] => 13/967389
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 48630
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967389 | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis | Aug 14, 2013 | Issued |
Array
(
[id] => 9496793
[patent_doc_number] => 08735611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Crystalline forms of cabazitaxel'
[patent_app_type] => utility
[patent_app_number] => 13/965015
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 8832
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13965015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/965015 | Crystalline forms of cabazitaxel | Aug 11, 2013 | Issued |
Array
(
[id] => 9319395
[patent_doc_number] => 20140051733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/964731
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6418
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/964731 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS | Aug 11, 2013 | Abandoned |
| 13/964033 | USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE DISORDERS INCLUDING NICOTINE ADDICTION | Aug 8, 2013 | Abandoned |
Array
(
[id] => 9307263
[patent_doc_number] => 20140045937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/960999
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4576
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960999
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960999 | METHODS OF TREATING POLYCYSTIC OVARIAN SYNDROME USING CHLOROGENIC ACID | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9464012
[patent_doc_number] => 20140128439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Methods for Treating Gout Flares'
[patent_app_type] => utility
[patent_app_number] => 13/961848
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12598
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961848
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961848 | Methods for Treating Gout Flares | Aug 6, 2013 | Abandoned |
Array
(
[id] => 10102661
[patent_doc_number] => 09138431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Methods of treatment of histamine H-4 receptor-related pruritus'
[patent_app_type] => utility
[patent_app_number] => 13/960114
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4981
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/960114 | Methods of treatment of histamine H-4 receptor-related pruritus | Aug 5, 2013 | Issued |
Array
(
[id] => 9384577
[patent_doc_number] => 20140088059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'Compositions and Methods for Localized Drug Delivery through Mammary Papillae'
[patent_app_type] => utility
[patent_app_number] => 13/942686
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 21281
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942686
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/942686 | Compositions and methods for localized drug delivery through mammary papillae | Jul 14, 2013 | Issued |
Array
(
[id] => 9149077
[patent_doc_number] => 20130303600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'ANTI-ANGIOGENIC COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/941932
[patent_app_country] => US
[patent_app_date] => 2013-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3772
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941932 | Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients | Jul 14, 2013 | Issued |
Array
(
[id] => 12942406
[patent_doc_number] => 09833426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function
[patent_app_type] => utility
[patent_app_number] => 14/411169
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5173
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411169
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/411169 | Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function | Jun 27, 2013 | Issued |
Array
(
[id] => 10272651
[patent_doc_number] => 20150157648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2'
[patent_app_type] => utility
[patent_app_number] => 14/410754
[patent_app_country] => US
[patent_app_date] => 2013-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26478
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/410754 | NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2 | Jun 25, 2013 | Abandoned |
Array
(
[id] => 9263327
[patent_doc_number] => 20130345255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'TRPV1 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/922442
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25862
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922442
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922442 | TRPV1 antagonists | Jun 19, 2013 | Issued |
Array
(
[id] => 12924469
[patent_doc_number] => 09827201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-28
[patent_title] => Natural lubricant for direct compression and method for preparing natural tablet using the same
[patent_app_type] => utility
[patent_app_number] => 13/871529
[patent_app_country] => US
[patent_app_date] => 2013-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3184
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13871529
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/871529 | Natural lubricant for direct compression and method for preparing natural tablet using the same | Apr 25, 2013 | Issued |
Array
(
[id] => 13644611
[patent_doc_number] => 09848599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Co-crystals of 3-iodopropynyl butylcarbamate
[patent_app_type] => utility
[patent_app_number] => 14/391504
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 7196
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391504
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391504 | Co-crystals of 3-iodopropynyl butylcarbamate | Apr 8, 2013 | Issued |
Array
(
[id] => 11886919
[patent_doc_number] => 09757465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-12
[patent_title] => 'Composition comprising an organic diluent and a cellulose ether'
[patent_app_type] => utility
[patent_app_number] => 14/390049
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12331
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390049
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390049 | Composition comprising an organic diluent and a cellulose ether | Apr 7, 2013 | Issued |